Hyerim Ha
-
- Cancer Immunotherapy and Biomarkers 5
- Inflammatory Biomarkers in Disease Prognosis 3
-
- Lymphoma Diagnosis and Treatment 5
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
-
- Economic and Financial Impacts of Cancer 4
-
- Acute Myeloid Leukemia Research 3
-
- Acute Lymphoblastic Leukemia research 3
-
- Statistical Methods in Clinical Trials 3
- Co-authors
- Do‐Youn OhYung‐Jue BangTae‐You KimSeock‐Ah ImKyung-Hun LeeSae‐Won HanTae‐Yong KimJu‐Hee Bang
- Journals
- Journal of Clinical Oncology (4 papers)SHILAP Revista de lepidopterología (1 paper)Cancer (1 paper)
- Partner nations
- South KoreaEthiopiaUnited States
In The Last Decade
Hyerim Ha
24 papers receiving 372 citations
Peers
Comparison fields: 5 of 77
- Oncology 222
- Internal Medicine 16
- Immunology and Allergy 25
- Pathology and Forensic Medicine 67
- Surgery 129
Countries citing papers authored by Hyerim Ha
This map shows the geographic impact of Hyerim Ha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyerim Ha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyerim Ha more than expected).
Fields of papers citing papers by Hyerim Ha
This network shows the impact of papers produced by Hyerim Ha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyerim Ha. The network helps show where Hyerim Ha may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hyerim Ha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 6 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 9 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 9 | |
| 11 | 2020 | 12 | |
| 12 | 2020 | 10 | |
| 13 | 2020 | 1 | |
| 14 | 2019 | 21 | |
| 15 | 2018 | 14 | |
| 16 | 2017 | 5 | |
| 17 | 2016 | 86 | |
| 18 | 2015 | 9 | |
| 19 | 2014 | 45 | |
| 20 | 2014 | 7 |
About Hyerim Ha
Hyerim Ha is a scholar working on Internal Medicine, Oncology and Statistics and Probability, having authored 25 papers that have together received 376 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Economic and Financial Impacts of Cancer (4 papers), Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers) and Statistical Methods in Clinical Trials (3 papers). The work is most often cited by research in Oncology (222 citations), Internal Medicine (16 citations) and Immunology and Allergy (25 citations). Hyerim Ha has collaborated with scholars based in South Korea, Ethiopia and United States. Frequent co-authors include Do‐Youn Oh, Yung‐Jue Bang, Tae‐You Kim, Seock‐Ah Im, Kyung-Hun Lee, Sae‐Won Han, Tae‐Yong Kim, Ju‐Hee Bang, Dae Seog Heo and Bhumsuk Keam. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.